Search research articles
Contact Us
Filters
Showing results (121-130 of 155) with videos related to
Page
of 16
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 1, 1994
A phase II study of Gemcitabine (LY 188011) in patients with advanced squamous cell carcinoma of the head and neck. EORTC Early Clinical Trials Group
G Catimel, J B Vermorken, M Clavel, et al.
British Journal of Cancer
|
June 1, 1994
Subcutaneous low-dose recombinant interleukin 2 and alpha-interferon in patients with metastatic renal cell carcinoma
A Ravaud, S Négrier, L Cany, et al.
Cancer
|
September 15, 1987
Combination chemotherapy with methotrexate, bleomycin, and vincristine with or without cisplatin in advanced squamous cell carcinoma of the head and neck
M Clavel, F Cognetti, P Dodion, et al.
Enfermeria Intensiva
|
March 29, 2001
[Measurement of care time in patients with acute myocardial infarction admitted to a general ICU: evaluation and improvement]
J J Rodríguez Mondéjar, M Clavel Amo, M M Cevidanes Lara, et al.
Anti-Cancer Drugs
|
February 1, 1996
Phase I and pharmacology study of intoplicine (RP 60475; NSC 645008), novel topoisomerase I and II inhibitor, in cancer patients
D Abigerges, J P Armand, G G Chabot, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie
|
April 1, 1993
[Immunotherapy of metastatic kidney cancer]
S Négrier, A Mercatello, B Coronel, et al.
European Journal of Cancer & Clinical Oncology
|
October 1, 1987
A phase II study of carboplatin in advanced or metastatic stomach cancer
M Beer, F Cavalli, S B Kaye, et al.
British Journal of Cancer
|
May 1, 1992
Intravenous interleukin-2 in patients over 65 with metastatic renal carcinoma
S Négrier, A Mercatello, M Bret, et al.
Journal of Biological Response Modifiers
|
June 1, 1990
Phase II study of recombinant human interferon-gamma in metastatic renal cell carcinoma
U Bruntsch, P H de Mulder, W W ten Bokkel Huinink, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 13, 2000
Multivariable analysis of prognostic factors for toxicity and survival for patients enrolled in phase I clinical trials
T Bachelot, I Ray-Coquard, G Catimel, et al.
Page
of 16
Search research articles
Search
Showing results (121-130 of 155) with videos related to
Sort By:
Page
of 16
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 1, 1994
A phase II study of Gemcitabine (LY 188011) in patients with advanced squamous cell carcinoma of the head and neck. EORTC Early Clinical Trials Group
G Catimel, J B Vermorken, M Clavel, et al.
British Journal of Cancer
|
June 1, 1994
Subcutaneous low-dose recombinant interleukin 2 and alpha-interferon in patients with metastatic renal cell carcinoma
A Ravaud, S Négrier, L Cany, et al.
Cancer
|
September 15, 1987
Combination chemotherapy with methotrexate, bleomycin, and vincristine with or without cisplatin in advanced squamous cell carcinoma of the head and neck
M Clavel, F Cognetti, P Dodion, et al.
Enfermeria Intensiva
|
March 29, 2001
[Measurement of care time in patients with acute myocardial infarction admitted to a general ICU: evaluation and improvement]
J J Rodríguez Mondéjar, M Clavel Amo, M M Cevidanes Lara, et al.
Anti-Cancer Drugs
|
February 1, 1996
Phase I and pharmacology study of intoplicine (RP 60475; NSC 645008), novel topoisomerase I and II inhibitor, in cancer patients
D Abigerges, J P Armand, G G Chabot, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie
|
April 1, 1993
[Immunotherapy of metastatic kidney cancer]
S Négrier, A Mercatello, B Coronel, et al.
European Journal of Cancer & Clinical Oncology
|
October 1, 1987
A phase II study of carboplatin in advanced or metastatic stomach cancer
M Beer, F Cavalli, S B Kaye, et al.
British Journal of Cancer
|
May 1, 1992
Intravenous interleukin-2 in patients over 65 with metastatic renal carcinoma
S Négrier, A Mercatello, M Bret, et al.
Journal of Biological Response Modifiers
|
June 1, 1990
Phase II study of recombinant human interferon-gamma in metastatic renal cell carcinoma
U Bruntsch, P H de Mulder, W W ten Bokkel Huinink, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 13, 2000
Multivariable analysis of prognostic factors for toxicity and survival for patients enrolled in phase I clinical trials
T Bachelot, I Ray-Coquard, G Catimel, et al.
Page
of 16